Huge number of R&D folks were laid off from the Amgen headqulocated in Thousand Oaks on Nov. 1, 2017. The senior leadership is not giving out the exact number of people laid off to avoid bad publicity.
2 replies (most recent on top)
Now, it's covered by the media, even though the OP covered it first:
Two biotech giants — Amgen and Genentech — are laying off a combined 330 people at California facilities, both citing “organizational changes” as the primary reason for the cuts.
Amgen is shaking up its R&D department, eliminating 200 positions at its Thousand Oaks, CA and South San Francisco facilities by the end of this year, STAT reported Saturday. An Amgen spokesperson tells me the company is making organizational changes across the globe in regards to its R&D departments. This round of layoffs, however, mostly impacts facilities in California.
“Given the dynamic nature of our business and the need to ensure greater flexibility across our organization, we must continue to be increasingly efficient in our operational discipline and invest our resources in a way that ensures our continued scientific leadership,” the spokesperson said in an email. “The organizational changes last week are designed to support those efforts. As always, in making these difficult decisions we are committed to treating our staff with respect and compassion.”
It’s not the first big headcount cut Amgen’s made this year. In March, the company relocated, reassigned, and cut about 500 jobs in Thousand Oaks. The restructuring included 100 employees moving to research centers in Cambridge and South San Francisco, and 50 jobs relocated to Amgen’s new Tampa center.
Heard the same